Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
do not crush, chew, or break extended-release tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed 2 extended-release tablets in 24 hours. children under 12 years of age: do not use
store between 20° to 25°C (68° to 77°F)
(in each extended-release tablet)
Guaifenesin USP 1200 mg
Expectorant
Do not use
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)
1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
Distributed By: Innovus Pharmaceuticals, Inc.
5740 Kietzke Lane #300, Reno, Nevada 89511
www.crclehealth.com
Made in India
*Compare to the active
ingredient of Maximum
Strength Mucinex®
C•rcle™
NDC 57483-144-28
Maximum Strength
Guaifenesin
Extended-Release Tablets 1200 mg
Guaifenesin 1200 mg - Expectorant
RELIEVES CHEST CONGESTION
12
Hour
28 EXTENDED-RELEASE TABLETS
Actual Size
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57483-144 | 57483-144-28 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210453-001 | GUAIFENESIN | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | ||
| A210453-002 | GUAIFENESIN | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5d02ea3f76ae… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.